Stock Market Today, Feb. 23: Novo Nordisk Plunges 16% After Obesity Drug Falls Short
Novo Nordisk(US:NVO) The Motley Fool·2026-02-23 22:21Today, Feb. 23, 2026, a pivotal obesity‑drug trial setback forces investors to rethink Novo Nordisk’s strategy.NYSE : NVONovo NordiskToday's Change( -16.43 %) $ -7.79Current Price$ 39.63Key Data PointsMarket Cap$160BDay's Range$ 39.34 - $ 41.0952wk Range$ 39.34 - $ 93.80Volume98MAvg Vol21MGross Margin80.90 %Dividend Yield3.64 %Novo Nordisk (NVO 16.43%), a healthcare giant that develops and markets diabetes and obesity treatments, closed Monday at $39.63, down 16.43%. The stock fell after it announced CagriS ...